Price, one year
Price range
- Open
- ₹813.00
- High
- ₹822.00
- Low
- ₹791.00
- Previous close
- ₹817.00
- Volume
- 8.8 L
- Market cap
- ₹21,679 Cr
Key statistics
Results to 30 Jun 2026 · Consolidated- P/E (TTM)
- 29.4
- Price to book
- 4.3
- Return on equity
- 13.0%
- EPS (TTM)
- ₹27.06
- Book value / share
- ₹186.41
- Debt to equity
- 0.26
- Revenue (TTM)
- ₹5,632 Cr
- Net profit (TTM)
- ₹662 Cr
- Sales growth, YoY
- +22.0%
- Profit growth, YoY
- +63.0%
- Operating margin
- 22.7%
- Net margin
- 11.8%
- Sales CAGR, 3 years
- +6.0%
- Profit CAGR, 3 years
- +4.8%
- Promoter holding
- 37.39%
- Promoter shares pledged
- 0.00%
Shareholding pattern
% of shares| Holder | Jun 2026 | Sep 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 38.02 | 37.39 | 37.39 |
| Foreign institutions | 17.50 | 20.29 | 20.25 |
| Domestic institutions | 16.11 | 15.40 | 15.33 |
| Mutual funds | 3.45 | 4.18 | 4.26 |
| Retail and others | 17.84 | 17.84 | 17.93 |
Results and announcements
Latest results (quarter to 30 Jun 2026) filed 21 Jul 2026. results: 2 Nov 2026.
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | ₹1,748.00 | −0.57% |
| Divi's LaboratoriesDIVISLAB | ₹8,950.00 | −2.31% |
| Torrent PharmaceuticalsTORNTPHARM | ₹4,524.40 | −1.97% |
| Zydus LifesciencesZYDUSLIFE | ₹1,129.40 | −0.49% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,730.00 | +1.65% |
| CiplaCIPLA | ₹1,338.00 | +0.53% |
| Laurus LabsLAURUSLABS | ₹1,970.00 | −1.62% |
| Dr. Reddy's LaboratoriesDRREDDY | ₹1,229.50 | −0.77% |
| Mankind PharmaMANKIND | ₹2,212.60 | −2.77% |
| Aurobindo PharmaAUROPHARMA | ₹1,571.70 | −2.43% |
Frequently asked questions
What is the share price of Granules India today?
Granules India (NSE: GRANULES) was at ₹794.75 on 23 Oct 2026, a change of −2.72% from the previous close.
What are the 52-week high and low of Granules India?
Over the last 52 weeks Granules India traded between ₹529.85 and ₹923.65 (daily highs and lows on NSE on 23 Oct 2026).
What is the market capitalisation of Granules India?
About ₹21,679 Cr at the latest price, with a P/E of 29.4, a price-to-book of 4.3, a return on equity of 13.0%. Ratios use the company's latest reported results.
Who owns Granules India shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 37.39%, foreign institutions 20.25%, domestic institutions 15.33%.
Which sector and indices does Granules India belong to?
NSE classifies Granules India under Healthcare; it is a member of Nifty 500.
Follow Granules India with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Start free trial